Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsRegistriesGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesTransplantation ConditioningAnemia, AplasticHematopoietic Stem Cell TransplantationLiver TransplantationLeukemiaTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsKidney TransplantationTransplantation, IsogeneicCyclophosphamideBone Marrow DiseasesRecurrenceHematopoiesisTreatment OutcomeCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationGraft RejectionImmunosuppressive AgentsHematologic NeoplasmsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyLiving DonorsBone Marrow NeoplasmsGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionHeart TransplantationLeukocyte TransfusionLymphocyte DepletionStem Cell TransplantationAcute DiseaseRetrospective StudiesLymphoma, Non-HodgkinSurvival AnalysisHLA AntigensT-LymphocytesSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayMyelodysplastic SyndromesLung TransplantationFollow-Up StudiesActuarial AnalysisCyclosporineHematologic DiseasesBlood DonorsBone DensitySurvival RateLymphocyte TransfusionOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorDisease-Free SurvivalMice, Inbred BALB CBone ResorptionMelphalanFlow CytometryLymphomaEtoposidePrognosisMultiple MyelomaCells, CulturedFatal OutcomeHodgkin DiseaseAntigens, CD34InfectionCord Blood Stem Cell Transplantation